CXCL10 and cancer: In this regard, and even though IP-10/CXCL10 has an influence on the trafficking of autoaggressive cells during development of several autoimmune diseases, mainly type 1 diabetes [35], to our knowledge this was the first time that IP-10/CXCL10’s predictive capacity regarding PFS and cancer-associated mortality was demonstrated in FOLFIRINOX-treated subcohort.